Correlation Between Pliant Therapeutics and Fennec Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Pliant Therapeutics and Fennec Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pliant Therapeutics and Fennec Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pliant Therapeutics and Fennec Pharmaceuticals, you can compare the effects of market volatilities on Pliant Therapeutics and Fennec Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pliant Therapeutics with a short position of Fennec Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pliant Therapeutics and Fennec Pharmaceuticals.
Diversification Opportunities for Pliant Therapeutics and Fennec Pharmaceuticals
-0.2 | Correlation Coefficient |
Good diversification
The 3 months correlation between Pliant and Fennec is -0.2. Overlapping area represents the amount of risk that can be diversified away by holding Pliant Therapeutics and Fennec Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Fennec Pharmaceuticals and Pliant Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pliant Therapeutics are associated (or correlated) with Fennec Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Fennec Pharmaceuticals has no effect on the direction of Pliant Therapeutics i.e., Pliant Therapeutics and Fennec Pharmaceuticals go up and down completely randomly.
Pair Corralation between Pliant Therapeutics and Fennec Pharmaceuticals
Given the investment horizon of 90 days Pliant Therapeutics is expected to under-perform the Fennec Pharmaceuticals. But the stock apears to be less risky and, when comparing its historical volatility, Pliant Therapeutics is 1.77 times less risky than Fennec Pharmaceuticals. The stock trades about -0.12 of its potential returns per unit of risk. The Fennec Pharmaceuticals is currently generating about 0.07 of returns per unit of risk over similar time horizon. If you would invest 446.00 in Fennec Pharmaceuticals on August 24, 2024 and sell it today you would earn a total of 26.00 from holding Fennec Pharmaceuticals or generate 5.83% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Pliant Therapeutics vs. Fennec Pharmaceuticals
Performance |
| Timeline |
| Pliant Therapeutics |
| Fennec Pharmaceuticals |
Pliant Therapeutics and Fennec Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Pliant Therapeutics and Fennec Pharmaceuticals
The main advantage of trading using opposite Pliant Therapeutics and Fennec Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pliant Therapeutics position performs unexpectedly, Fennec Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Fennec Pharmaceuticals will offset losses from the drop in Fennec Pharmaceuticals' long position.| Pliant Therapeutics vs. Lyra Therapeutics | Pliant Therapeutics vs. Hookipa Pharma | Pliant Therapeutics vs. Cingulate Warrants | Pliant Therapeutics vs. SAB Biotherapeutics |
| Fennec Pharmaceuticals vs. Lyra Therapeutics | Fennec Pharmaceuticals vs. Hookipa Pharma | Fennec Pharmaceuticals vs. Cingulate Warrants | Fennec Pharmaceuticals vs. SAB Biotherapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.
Other Complementary Tools
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities |